Expert Interview
A Second Look: Discussing the results from the Phase 1 study evaluating the safety and tolerability of Lepodisiran in healthy participants with high lipoprotein(a) levels
Ticker(s): LLYInstitution: Thomas Jefferson University
- Clinical Associate Professor of Medicine (Cardiology) at Thomas Jefferson University Hospital and practicing clinical cardiologist for 44 years.
- Currently manages 600 patients with cardiovascular disease.
- Familiar and comfortable discussing the results from the Phase 1 studying evaluating the safety and tolerability of Lepodisiran.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
